A Herpesvirus Relapse, After a L-arginine Overload as a Possible Trigger, and the Therapeutic Use of Its Antagonist Competitor L-lysine: Brief Review and Case Report

Abstract Introduction: Arginine may be associated with the latent herpesvirus reactivation and L-lysine has been shown to inhibit certain viral replication phases by antagonizing arginine. Case Presentation: Man with latent HHV-1 experienced work-related stress but only after an arginine overloud, an initial recurrent labial herpes was observed. A loading dose of L-lysine was prescribed that day, followed by a maintenance dose for 30 days. Arginine-rich foods and supplements are avoided. By the sixth day, only redness, indicating the final healing stage. Conclusion: In the presence of stress, it is advisable to avoid arginine consumption, as this may expose the individual to multiple triggers, increasing the likelihood of relapse. In this case, the lysine administration, along with a reduction in arginine intake, proved effective in controlling the episode. Further epidemiological and larger-scale studies are needed to confirm the relationship between latent virus reactivation and arginine overload.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-06-24
DOI
https://doi.org/10.5281/zenodo.15881514
Primary Topic
Cytomegalovirus and herpesvirus research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Herpesvirus Relapse, After a L-arginine Overload as a Possible Trigger, and the Therapeutic Use of Its Antagonist Competitor L-lysine: Brief Review and Case Report

Zenodo (CERN European Organization for Nuclear Research)
Cytomegalovirus and herpesvirus research
article

A Herpesvirus Relapse, After a L-arginine Overload as a Possible Trigger, and the Therapeutic Use of Its Antagonist Competitor L-lysine: Brief Review and Case Report

article en

Abstract

Abstract Introduction: Arginine may be associated with the latent herpesvirus reactivation and L-lysine has been shown to inhibit certain viral replication phases by antagonizing arginine. Case Presentation: Man with latent HHV-1 experienced work-related stress but only after an arginine overloud, an initial recurrent labial herpes was observed. A loading dose of L-lysine was prescribed that day, followed by a maintenance dose for 30 days. Arginine-rich foods and supplements are avoided. By the sixth day, only redness, indicating the final healing stage. Conclusion: In the presence of stress, it is advisable to avoid arginine consumption, as this may expose the individual to multiple triggers, increasing the likelihood of relapse. In this case, the lysine administration, along with a reduction in arginine intake, proved effective in controlling the episode. Further epidemiological and larger-scale studies are needed to confirm the relationship between latent virus reactivation and arginine overload.

Zenodo (CERN European Organization for Nuclear Research)
Universidade Estadual de Campinas (UNICAMP) (BR), Methodist University of Piracicaba (BR), Faculdade São Leopoldo Mandic (BR), Universidade Federal do Paraná (BR), Chicago State University (US), Universidade Positivo (BR)
Good health and well-being
Openalex Percentile: Top 45%
Cytomegalovirus and herpesvirus research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Herpesvirus Relapse, After a L-arginine Overload as a Possible Trigger, and the Therapeutic Use of Its Antagonist Competitor L-lysine: Brief Review and Case Report · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS